Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Ottawa

$105,000.00

Determining the subnuclear localization of alpha-synuclein and the molecular mechanisms of nuclear alpha-synuclein toxicity

EF 2021-22

Résumé
The molecular mechanisms underlying the pathogenesis of Parkinson's disease (PD) have been difficult to establish. However, studying alpha-synuclein (aSyn) - a known protein involved in PD pathology - has shed important light on some of these mechanisms. aSyn is primarily pre-synaptic and, at lower levels, nuclear. However, in PD, nuclear aSyn increases. I previously determined that increasing nuclear aSyn in mice, using the Snca-NLS mice which translocates aSyn to the nucleus, elicits motor dysfunction and cortical atrophy. The role of nuclear aSyn has not been well characterized, both in health and disease states. Therefore, I propose to better understand the molecular mechanisms of nuclear aSyn. First, I will determine the precise subnuclear localization of aSyn using two different microscopy techniques in primary cortical neurons, mouse brain, and PD patient brain tissue. Locating where aSyn exists in the nucleus will give clues to its nuclear function. We can then compare the localization in wildtype or healthy tissue to that of homozygous Snca-NLS mouse or PD patient tissue to determine how its localization changes in disease. Secondly, aSyn has been shown to bind to DNA and elicit changes in gene expression. To better understand this function of nuclear aSyn, I will determine where aSyn is binding to DNA and how aSyn is changing gene expression. From here, I will design dCas9-fusion proteins (dCas9, deactivated Cas9) to target the binding of aSyn to DNA using the specificity of Cas9 without its cleavage activity. Mapping where aSyn binds to DNA and changes gene expression will enable a more comprehensive understanding of the function of nuclear aSyn. Together, these two aims will be used to better elucidate the molecular mechanisms of nuclear aSyn natively and in disease.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
458905
Name
Geertsma Haley
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Determining the subnuclear localization of alpha-synuclein and the molecular mechanisms of nuclear alpha-synuclein toxicity
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Alpha-Synuclein; Confocal Microscopy; Crispr; Cut&Run; Dcas9; Immuno-Electron Microscopy; Parkinson'S Disease; Subnuclear Localization
Abstract
The molecular mechanisms underlying the pathogenesis of Parkinson's disease (PD) have been difficult to establish. However, studying alpha-synuclein (aSyn) - a known protein involved in PD pathology - has shed important light on some of these mechanisms. aSyn is primarily pre-synaptic and, at lower levels, nuclear. However, in PD, nuclear aSyn increases. I previously determined that increasing nuclear aSyn in mice, using the Snca-NLS mice which translocates aSyn to the nucleus, elicits motor dysfunction and cortical atrophy. The role of nuclear aSyn has not been well characterized, both in health and disease states. Therefore, I propose to better understand the molecular mechanisms of nuclear aSyn. First, I will determine the precise subnuclear localization of aSyn using two different microscopy techniques in primary cortical neurons, mouse brain, and PD patient brain tissue. Locating where aSyn exists in the nucleus will give clues to its nuclear function. We can then compare the localization in wildtype or healthy tissue to that of homozygous Snca-NLS mouse or PD patient tissue to determine how its localization changes in disease. Secondly, aSyn has been shown to bind to DNA and elicit changes in gene expression. To better understand this function of nuclear aSyn, I will determine where aSyn is binding to DNA and how aSyn is changing gene expression. From here, I will design dCas9-fusion proteins (dCas9, deactivated Cas9) to target the binding of aSyn to DNA using the specificity of Cas9 without its cleavage activity. Mapping where aSyn binds to DNA and changes gene expression will enable a more comprehensive understanding of the function of nuclear aSyn. Together, these two aims will be used to better elucidate the molecular mechanisms of nuclear aSyn natively and in disease.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Geertsma, Haley
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~